Intersect ENT Inc (NASDAQ:XENT) Share Price

Company Profile

Intersect ENT Inc are a commercial drug delivery company committed to improving the quality of life for patients with ear, nose and throat conditions. It offer's PROPEL and PROPEL mini drug-releasing implants for patients undergoing sinus surgery to treat chronic sinusitis and PROPEL contour, a steroid-releasing implant to frontal and maxillary sinus ostia or openings of the dependent sinuses. The company generates revenues from the sale of our PROPEL family of products.Intersect ENT Inc is a commercial stage drug-device company engaged in improving the life for patients with ear, nose and throat conditions.